Oncology
 |
|
11 january 2019 17:00:27 |
| BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis (Oncogene) |
|
Tweet |
| 59 viewsCategory: Oncology |
 B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells (Oncogene)Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
